COVID-19 vaccine equity: a health systems and policy perspective

Van De Pas R.; Widdowson M.-A.; Ravinetto R.; N Srinivas P.; Ochoa T.J.; Fofana T.O.; Van Damme W. · Expert Review of Vaccines (2022) · DOI: 10.1080/14760584.2022.2004125

Resumen

Introduction: The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID-19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. Areas covered: This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. Expert opinion: All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool and supported by a just Intellectual Property regime. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.

Instituciones: Universidad Peruana Cayetano Heredia